Mark A. Schlossberg

R.J. Reynolds Tobacco Holdings, Inc. manufactures and markets cigarettes and tobacco products. The company was founded in 1970 and is headquartered in Winston-Salem, NC.

Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ.

ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ.

Angiologix, Inc. provides cardiovascular diagnostic products. It serves physician-specialists, cardiologists, vascular medicine, endocrinologists, and primary care physicians. The company was founded in 2007 and is headquartered in Mountain View, CA.

Part of Diageo Plc, Diageo India Pvt Ltd. is an Indian company that manufactures and wholesales wines and spirits. The company is based in Mumbai, India. The company was founded in 1993 by Deepak Shashibhusan Roy. Abanti Sankaranarayanan has been the CEO of the company since 2010.